[HTML][HTML] Advances and challenges in the treatment of lung cancer
Y Li, B Yan, S He - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Lung cancer accounts for a relatively high proportion of malignant tumors. As the most
prevalent type of lung cancer, non-small cell lung cancer (NSCLC) is characterized by high …
prevalent type of lung cancer, non-small cell lung cancer (NSCLC) is characterized by high …
Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis
W Kang, X Qiu, Y Luo, J Luo, Y Liu, J Xi, X Li… - Journal of Translational …, 2023 - Springer
The advent of immunotherapy, a groundbreaking advancement in cancer treatment, has
given rise to the prominence of the tumor microenvironment (TME) as a critical area of …
given rise to the prominence of the tumor microenvironment (TME) as a critical area of …
Tumor-infiltrating lymphocytes for melanoma immunotherapy
Oncological routine has incorporated the regular use of monoclonal antibodies targeting
checkpoints of T cell function such as ipilimumab, which blocks cytotoxic T-lymphocyte …
checkpoints of T cell function such as ipilimumab, which blocks cytotoxic T-lymphocyte …
Focus on T cell exhaustion: new advances in traditional Chinese medicine in infection and cancer
S Li, L Hao, J Zhang, J Deng, X Hu - Chinese Medicine, 2023 - Springer
In chronic infections and cancers, T lymphocytes (T cells) are exposed to persistent antigen
or inflammatory signals. The condition is often associated with a decline in T-cell function: a …
or inflammatory signals. The condition is often associated with a decline in T-cell function: a …
[HTML][HTML] ATP2C2 as a novel immune-related marker that defines the tumor microenvironment in triple-negative breast cancer
M Zhao, Q Zhang, Z Song, H Lei, J Li… - Translational Cancer …, 2023 - ncbi.nlm.nih.gov
Background Triple-negative breast cancer (TNBC) is an aggressive cancer that affects about
13/100,000 women yearly. Patients with TNBC are often resistant to endocrine and …
13/100,000 women yearly. Patients with TNBC are often resistant to endocrine and …
Relación entre la expresión de ID1 e ID3 y el microambiente tumoral inmune de la médula ósea en adultos con leucemia linfoblástica aguda de células precursoras B
JN Poveda Garavito - repositorio.unal.edu.co
El diagnóstico de leucemia linfoblástica aguda de precursores de células B (BCP-ALL) es
una condición que generalmente presenta un pronóstico desfavorable. Investigaciones …
una condición que generalmente presenta un pronóstico desfavorable. Investigaciones …